Treatment

Antiretroviral therapy may be stabilising HIV epidemic in Danish gay men

published: June, 08, 2012 Categories // As Prevention , Research, Health, Revolving Door, Treatment, Guest Authors

New Danish research, aidsdmap reports, suggests stabilising of the epidemic in that country is due to antiretroviral therapy rather than changes in sexual behaviour

Antiretroviral therapy may be stabilising HIV epidemic in Danish gay men

This article by Michael Carter originally published by NAM/www.aidsmap.com is republished with permission. The use of antiretroviral treatment appears to have stabilised the HIV epidemic in Danish gay men, even though rates of risky sex have increased, research published in the online edition of the Journal of Acquired Immune Deficiency Syndromes suggests. “While unsafe sex among MSM [men who have sex with men] has increased substantially and the number of HIV-positive MSM living in Denma

The Advantages of Once Daily Dosing

published: June, 06, 2012 Written by // Bob Leahy - Publisher Categories // OHTN OHTN/PositiveLite.com, Research, Features and Interviews, Health, Treatment, Living with HIV, Bob Leahy - Publisher

When it comes to adherence (taking medications as prescribed and not missing doses) do HIVers do better on regimes requiring only one dose a day? The Ontario HIV Treatment Network (OHTN) Cohort Study (OCS) has the answers.

The Advantages of Once Daily Dosing

Photo © Joyb0218 | Dreamstime.com   Bob Leahy writes: I’ll try not to salivate at the prospect of one dose a day.  But I was diagnosed in 1993. In 1995-96 I took part in the clinical trial of  the first of the protease inhibitors, saquinavir, quickly becoming resistant to that class of drugs because of suboptimal doses that were prescribed back then. Like it or not, past resistance issues, even in the most adherent of us, tend to lead to multiple drug cocktails. Until recently I was o

Views from the front lines: Pre-exposure prophylaxis

published: June, 01, 2012 Written by // Guest Authors - Revolving Door Categories // CATIE, Sexual Health, Health, Revolving Door, Treatment, Guest Authors, Opinion Pieces, Sex and Sexuality

CATIE asked four people who work within the HIV community to give their pesrpectuves on Pre-exposure Prophylaxis (PrEP).

Views from the front lines: Pre-exposure prophylaxis

This article first appeared in Prevention in Focus , Spring 2011 edition, a publication of CATIE.  Une version française est disponible ici.  We spoke to four people with very different perspectives on PrEP. Dr. Mark Tyndall—Professor of Medicine, University of Ottawa Dr. Peter A. Newman—Associate Professor, Faculty of Social Work, University of Toronto Canada Research Chair in Health and Social Justice Jody Jollimore—Program Manager, Health Initiative for Men, Vancouver, Brit

Our Series on Neuropathy – Part Three

published: May, 26, 2012 Categories // Health, Treatment, Living with HIV

Guest writer and neuropathy expert Dave R. on “How Neuropathy Is Currently Treated.”

Our Series on Neuropathy – Part Three

It is probably best to be brutally honest here: neuropathy is essentially nerve damage and as of writing, there is no cure for nerve damage and nerves where the cells are dead cannot be repaired. Anyone who claims to be able to "cure" your neuropathy is exaggerating at best! That said, many of the worst aspects of neuropathy, and that means the symptoms, can be helped or alleviated, so that life becomes more bearable. Doctors may also tell you that some forms of neuropathy can be cured but th

There is no vaccine for HIV

published: May, 24, 2012 Categories // As Prevention , Health, Treatment, Opinion Pieces

Christopher Banks on Prep: "We want to give this to people who have nothing wrong with them at all? To stop them acquiring a virus that is already completely preventable by sliding a bit of latex over the end of your penis . . .?"

There is no vaccine for HIV

This post originally appeared on Bipolar Bear, and was written by Christopher Banks. Christopher Banks is a filmmaker, journalist and musician with experience of bipolar disorder. He has co-edited New Zealand's most popular magazine for HIV positive people, Collective Thinking, worked for the New Zealand AIDS Foundation and the Access To Medicines Coalition, a lobby group calling for wider and increasing funding for antiretrovirals. He writes five times a week for his blog Bipolar Bear (www.b

Adding Some New Meds to the Mix

published: May, 21, 2012 Written by // Wayne Bristow - Positive Life Categories // Health, Treatment, Living with HIV, Wayne Bristow

Wayne Bristow updates us on treatments he’s now started taking for peripheral neuropathy and for calcium deficiency

Adding Some New Meds to the Mix

I’m having success with two new meds, One has helped me improve two areas - walking and sleeping, but is it just a temporary fix? The other medications? Well, read on……… At my last doctor’s visit I was telling him again that I was having troubles when going on my hikes. After walking long distances or standing in one spot for long periods of time, it felt like I was standing in bare feet on a bed of stones. I would always have to shift from one foot to the other to take the pressure

The once-a-day HIV Prevention Pill.

published: May, 13, 2012 Written by // Guest Authors - Revolving Door Categories // As Prevention , Sexual Health, Health, Revolving Door, Treatment, Guest Authors

PreP gets one step closer to reality. Truvada appears safe for HIV prevention, FDA says and may be approved for people at risk.

The once-a-day HIV Prevention Pill.

From The Associated Press via CTV News  WASHINGTON —  U.S. drug regulators on Tuesday affirmed landmark study results showing that a popular HIV-fighting pill can also help healthy people avoid contracting the virus that causes AIDS in the first place. While the pill appears safe and effective for prevention, scientists stressed that it only works when taken on a daily basis. The Food and Drug Administration will hold a meeting Thursday to discuss whether Truvada should be approved for p

The Connections: Poverty, Homelessness and HIV

published: May, 06, 2012 Written by // Guest Authors - Revolving Door Categories // Revolving Door, Treatment, Lifestyle, Guest Authors, Living with HIV

Guest Post: A UCSF Study shows poverty undercuts otherwise major gains in HIV treatment

The Connections: Poverty, Homelessness and HIV

This article by Jeff Sheehy was first posted on the website of University of California, San Francisco (UCSF) here.  Published with permission.   In a groundbreaking study published last year, scientists reported that effective treatment with HIV medications not only restores health and prolongs life in many HIV-infected patients, but also curtails transmission to sexual partners up to ninety-seven percent. However, a new study by UCSF scientists shows that lack of basic living needs sever

Treatments on Trial (le français suit)

published: May, 04, 2012 Written by // CATIE - HIV and Hep C Info Resource Categories // CATIE, Health, CATIE - HIV and Hep C Info Resource, Treatment, Living with HIV

CATIE highlights resources for PHAs thinking about joining a clinical trial.

Treatments on Trial (le français suit)

As the warmer weather approaches, so does the HIV research conference season. Yes, we get excited about HIV research conferences here at CATIE. In late April, the Canadian HIV research community gathered for the annual conference put on by the Canadian Association of HIV Research —known to us HIV geeks as the CAHR conference. And of course, the big biennial International AIDS Conference is being held in July in Washington, DC. It becomes very evident during an HIV research conference that

Holidazed.

published: May, 02, 2012 Categories // Health, International , Treatment, Living with HIV

Travelling woes: J from Singapore is stranded for three days without HIV meds.

My best friend and I just came back from a vacation from Manila a few days ago. It was supposed to be a quick five-day unwinding involving the beach, the mountains, the shopping and of course nightlife. We covered those bases as planned; the unexpected was the three extended days of personal hell. At least that’s what the agony of not having access to anti-retroviral medication felt like. It isn’t so much what non-medication in the moment does at that moment in time, but its implications i

It's gone down to how much?

published: April, 15, 2012 Written by // Guest Authors - Revolving Door Categories // Newly Diagnosed, Health, Revolving Door, Treatment, Guest Authors, Living with HIV, Population Specific

We love posts like this! Newly diagnosed guest writer Richard T checks back in with his latest lab work results - he started treatment recently - and they’re really good!

It's gone down to how much?

Follow the links to Richard T.’s previous posts for PositiveLite.com under "Related Articles" below. I woke up early and felt like a teenager who had to ring up for their examination results. I normally email my nurse for the results of my blood tests but this time, as I hadn't spoken with her for a while, felt that phoning would be better and a bit more social. So six weeks after treatment began, I have updated my graph with my latest results from the clinic. (see below) A picture does sa

HIV and the Older Patient

published: April, 04, 2012 Written by // Guest Authors - Revolving Door Categories // General Health, Newly Diagnosed, Health, Revolving Door, Treatment, Guest Authors, Living with HIV, Population Specific

New US HIV Treatment Guidelines which discuss when to start antiretroviral therapy also include an important new section on HIV and the older patient.

HIV and the Older Patient

Editor’s note:  The most eye-catching piece of information here – and this is new - is the statement that if you’re living with HIV, over 50 years of age and haven’t yet started antiretroviral (ARV) therapy, the U.S. Department of Health and Human Services now recommend HIV treatment, regardless of your CD4 cell count. PositiveLite.com discussed the guidelines relating to the general  HIV-positive population here. Today we focus specifically on the section relating to HIV and aging

When to start treatment?

published: April, 03, 2012 Written by // Bob Leahy - Publisher Categories // Current Affairs, Treatment Guidelines -including when to start, Health, Treatment, Living with HIV, Opinion Pieces, Bob Leahy - Publisher

New US guidelines released just last week recommend treatment for all people with HIV infection. Are they a step in the right direction, something that others should consider following? Bob Leahy reports.

When to start treatment?

Newly updated US treatment guidelines are recommending antiretroviral treatment for all people with HIV infection, rather than starting at a particular CD4 range. But for those about to start treatment and their doctors, it’s not quite that simple; the strength of the recommendations varies by category of patient. Here is how a simplified scale looks: CD4 count less than 350 – strong recommendation CD4 count 350 to 500 - strong recommendation CD4 count over 500 – moderate recommend

Recently infected individuals: A priority for HIV prevention

published: March, 31, 2012 Written by // Guest Authors - Revolving Door Categories // CATIE, Newly Diagnosed, Sexual Health, Health, Revolving Door, Treatment, Guest Authors, Living with HIV, Population Specific , Sex and Sexuality

In this article, CATIE explores why recently infected individuals are more likely to transmit HIV to others and how we can help prevent these transmissions from occurring.

Recently infected individuals: A priority for HIV prevention

"Recently infected individuals: A priority for HIV prevention" by James Wilton first appeared in Prevention in Focus, Fall Issue 2011, a publication of CATIE. A French language version is available here.  People living with HIV can potentially transmit HIV to others through unprotected sex at any time during their life. However, emerging research suggests that a disproportionate number of HIV transmissions—perhaps more than half—may originate from people during the first few months aft

Prevention and its discontents

published: March, 22, 2012 Written by // Michael Bouldin Categories // As Prevention , Gay Men, Health, Treatment, Living with HIV, Opinion Pieces, Population Specific , Sex and Sexuality , Michael Bouldin

Michael Boudin says “walking a red light can get you killed; it can also get you to a job interview on time.”

Prevention and its discontents

In November of 2010, The New York Times wrote, under the headline ‘An AIDS Advance, Hiding in the Open’, about what at first and even second glance appeared to be a major step forward in HIV prevention: Pre-Exposure Prophylaxis, or PrEP. In the war against AIDS, a new weapon has emerged. It wasn’t a secret weapon. It was a well-established treatment pill that has only now been shown to be effective as a prevention pill too. Which raises a question: What took so long? Last week, a cl

<<  39 40 41 42 43 [4445 46 47  >>